Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006

被引:58
|
作者
Trotter, Caroline L. [1 ]
Waight, Pauline [2 ]
Andrews, Nick J. [3 ]
Slack, Mary [4 ]
Efstratiou, Androulla [4 ]
George, Robert [4 ]
Miller, Elizabeth [2 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England
[2] Ctr Infect, Hlth Protect Agcy, Immunisat Dept, London, England
[3] Ctr Infect, Hlth Protect Agcy, Stat Modelling & Econ Dept, London, England
[4] Ctr Infect, Hlth Protect Agcy, Resp & Syst Infect Lab, London, England
基金
美国国家卫生研究院;
关键词
Streptococcus pneumoniae; Invasive pneumococcal disease; Epidemiology; Meningitis; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; ADULTS;
D O I
10.1016/j.jinf.2009.12.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era. Methods: We analysed reports of culture-confirmed IPD submitted to the national surveillance system between July 1996 and June 2006. Results: The incidence of IPD was 10 per 100,000 overall, and increased over time. The typical pattern of IPD by age was observed, with the highest incidence in young children and older adults. There was little change in IPD incidence in the elderly, despite the widespread use of 23-valent pneumococcal polysaccharide vaccines since 2003. The distribution of serotypes changed over time; notably the proportion of cases caused by serotype 14 decreased, and the proportion due to serotype 1 increased. The incidence of meningitis was 0.6 per 100,000 overall, and as a proportion of all IPD cases was most common in children under 1 year of age (30%). Particular serotypes were significantly associated with a presentation of meningitis, after controlling for age and year, and the case: carrier ratio varied markedly by serotype. Conclusions: This paper provides a baseline for evaluating the impact of 7-valent pneumococcal conjugate vaccines, introduced in September 2006. Ongoing high-quality laboratory-based surveillance of IPD in all age groups is essential. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 50 条
  • [31] Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England
    Foster, Dona
    Walker, A. Sarah
    Paul, John
    Griffiths, David
    Knox, Kyle
    Peto, Timothy E.
    Crook, Derrick W.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (01) : 91 - 97
  • [32] Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine
    Hsu, K
    Pelton, S
    Karumuri, S
    Heisey-Grove, D
    Klein, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (01) : 17 - 23
  • [33] Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine
    Winther, Thilde N.
    Kristensen, Tim D.
    Kaltoft, Margit S.
    Konradsen, Helle B.
    Knudsen, Jenny D.
    Hogh, Birthe
    ACTA PAEDIATRICA, 2009, 98 (02) : 328 - 331
  • [34] Invasive pneumococcal disease in England and Wales: Vaccination implications
    Sleeman, K
    Knox, K
    George, R
    Miller, E
    Waight, P
    Griffiths, D
    Efstratiou, A
    Broughton, K
    Mayon-White, RT
    Moxon, ER
    Crook, DW
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02): : 239 - 246
  • [35] Wet cooling systems as a source of sporadic Legionnaires' disease: a geographical analysis of data for England and Wales, 1996-2006
    Ricketts, Kate D.
    Joseph, Carol A.
    Lee, John V.
    Wilkinson, Paul
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2012, 66 (07) : 618 - 623
  • [36] Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial
    Zangwill, KM
    Vadheim, CM
    Vannier, AM
    Hemenway, LS
    Greenberg, DP
    Ward, JI
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 752 - 759
  • [38] Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine
    Obando, I.
    Arroyo, L. A.
    Sanchez-Tatay, D.
    Tarrago, D.
    Moreno, D.
    Hausdorff, W. P.
    Brueggemann, A. B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) : 347 - 348
  • [39] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
    Waight, Pauline A.
    Andrews, Nicholas J.
    Ladhani, Shamez N.
    Sheppard, Carmen L.
    Slack, Mary P. E.
    Miller, Elizabeth
    LANCET INFECTIOUS DISEASES, 2015, 15 (05): : 535 - 543
  • [40] Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era
    de St Maurice, Annabelle
    Schaffner, William
    Griffin, Marie R.
    Halasa, Natasha
    Grijalva, Carlos G.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (05): : 792 - 797